Literature DB >> 9520149

Brain concentrations of asimadoline in mice: the influence of coadministration of various P-glycoprotein substrates.

H M Bender1, J Dasenbrock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9520149

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


× No keyword cloud information.
  7 in total

Review 1.  Kappa opioids and the modulation of pain.

Authors:  Bronwyn Kivell; Thomas E Prisinzano
Journal:  Psychopharmacology (Berl)       Date:  2010-04-07       Impact factor: 4.530

2.  Morphine antinociception is enhanced in mdr1a gene-deficient mice.

Authors:  J Zong; G M Pollack
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

3.  Kappa Opioid Receptor-Mediated Disruption of Novel Object Recognition: Relevance for Psychostimulant Treatment.

Authors:  Jason J Paris; Kate J Reilley; Jay P McLaughlin
Journal:  J Addict Res Ther       Date:  2011-12-24

4.  Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia.

Authors:  N J Talley; R S Choung; M Camilleri; R A Dierkhising; A R Zinsmeister
Journal:  Aliment Pharmacol Ther       Date:  2008-03-07       Impact factor: 8.171

5.  Treatment of Functional Dyspepsia.

Authors:  Silvia Delgado-Aros; Filippo Cremonini; Nicholas J. Talley
Journal:  Curr Treat Options Gastroenterol       Date:  2004-04

Review 6.  Novel pharmacology: asimadoline, a kappa-opioid agonist, and visceral sensation.

Authors:  M Camilleri
Journal:  Neurogastroenterol Motil       Date:  2008-09       Impact factor: 3.598

7.  Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review.

Authors:  Allen W Mangel; Gareth A Hicks
Journal:  Clin Exp Gastroenterol       Date:  2012-01-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.